SEARCH

SEARCH BY CITATION

References

  • 1
    Des Jarlais D., Bramson H., Wong C., Gostnell K., Cepeda J., Arasteh K. et al. Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction 2012; 107: 20872095.
  • 2
    Wood E., Montaner J. S., Li K., Zhang R., Barney L., Strathdee S. A. et al. Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health 2008; 98: 515519.
  • 3
    Wood E., Montaner J. S., Li K., Barney L., Tyndall M. W., Kerr T. Rate of methadone use among Aboriginal opioid injection drug users. Can Med Assoc J 2007; 177: 3740.
  • 4
    The Global Commission on Drug Policy. The War on Drugs and HIV/AIDS: How the Criminalization of Drug Use Fuels the Global Pandemic. 2012. Available at: http://www.globalcommissionondrugs.org/hivaids-pandemic/ (accessed 21 September 2012; archived at http://www.webcitation.org/6AqchpoQf).
  • 5
    Yirrell D. L., Robertson P., Goldberg D. J., McMenamin J., Cameron S., Leigh Brown A. J. Molecular investigation into outbreak of HIV in a Scottish prison. BMJ 1997; 314: 14461450.
  • 6
    Milloy M. J., Kerr T., Buxton J., Rhodes T., Guillemi S., Hogg R. et al. Dose–response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis 2011; 203: 12151221.
  • 7
    Westergaard R. P., Kirk G. D., Richesson D. R., Galai N., Mehta S. H. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis 2011; 53: 725731.
  • 8
    Johnson R., Raphael S. The effects of male incarceration dynamics on acquired immune deficiency syndrome infection rates among African American women and men. J Law Econ 2009; 52: 251293.
  • 9
    US Centers for Disease Control. Diagnoses of HIV infection and AIDS in the United States and dependent areas. 2009. Available at: http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/ (accessed 21 September 2012; archived at http://www.webcitation.org/6AqdlOr6L).
  • 10
    ASAM Writing Committee to Develop a Response to State-Level Proposals to Legalize Marijuana: DuPont R. L., Barthwell A. G., Kraus M., Sabet K., Soper R., Teitelbaum S. ASAM White Paper on State-Level Proposals to Legalize Marijuana. 2012. Available at: http://www.asam.org/policies/state-level-proposals-to-legalize-marijuana (accessed 21 September 2012; archived at http://www.webcitation.org/6Aqebp3CL).
  • 11
    Johnston L. D., O'Malley P. M., Bachman J. G., Schulenberg J. E. Monitoring the Future: National Survey Results on Drug Use, 1975–2005, vol. I. Secondary School Students. NIH publication no. 06-5883. Bethesda, MD: National Institute on Drug Abuse; 2006.
  • 12
    Roettger M. E., Swisher R. R., Kuhl D. C., Chavez J. Paternal incarceration and trajectories of marijuana and other illegal drug use from adolescence into young adulthood: evidence from longitudinal panels of males and females in the United States. Addiction 2011; 106: 121132.
  • 13
    Room R., Fischer B., Hall W., Lenton S., Reuter P. Cannabis Policy: Moving Beyond Stalemate. Oxford: Oxford University Press; 2010.
  • 14
    Werb D., Rowell G., Guyatt G., Kerr T., Montaner J., Wood E. Effect of drug law enforcement on drug market violence: a systematic review. Int J Drug Policy 2011; 22: 8794.
  • 15
    Room R. In thinking about cannabis policy, what can be learned from alcohol and tobacco? In: Sharon Rödner Sznitman , Börje Olsson , Robin Room , editors. A Cannabis Reader: Global Issues and Local Experiences. Monograph series no. 8, vol. 1. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2008, pp. 119135.
  • 16
    Nordt C., Stohler R. Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet 2006; 367: 18301834.